13D/13G Filings - Larimar Therapeutics Inc. (LRMR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
08:57 am
Unchanged
2020-12-3113GLarimar Therapeutics, Inc.
LRMR
SPHERA FUNDS MANAGEMENT LTD.0
0.000%
0
(Unchanged)
Filing
History
2021-02-16
06:11 am
Purchase
2020-12-3113GLarimar Therapeutics, Inc.
LRMR
ACUTA CAPITAL PARTNERS LLC863,100
5.600%
863,100increase
(New Position)
Filing
History
2021-02-12
4:57 pm
Purchase
2020-12-3113GLarimar Therapeutics, Inc.
LRMR
ORBIMED ADVISORS LLC732,323
4.770%
732,323increase
(New Position)
Filing
History
2021-02-10
7:02 pm
Purchase
2020-12-3113GLarimar Therapeutics, Inc.
LRMR
Renaissance Technologies LLC221,374
1.440%
221,374increase
(New Position)
Filing
History
2021-02-02
1:04 pm
Purchase
2020-12-3113GLarimar Therapeutics, Inc.
LRMR
Atlas Venture Fund VII L P292,182
1.900%
292,182increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2